Skip to content
Screener

Medtronic MDT Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Abbott logo
AbbottABT
$39.8B+44.2%
Intuitive Surgical logo
Intuitive SurgicalISRG
$394.3M+68.7%
Insulet logo
InsuletPODD
$191.6M+17.2%
Globus Medical logo
Globus MedicalGMED
$1.12B+1.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$14.09M
ITG
Integer HoldingsITGR
$1.3B+1.7%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The source filing: Medtronic’s 10-Q, filed February 24, 2026.

Filed
Feb 24, 2026, 4:18 PM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-011107
(in millions)January 23, 2026 / Gross Carrying AmountJanuary 23, 2026 / Accumulated AmortizationApril 25, 2025 / Gross Carrying AmountApril 25, 2025 / Accumulated Amortization
Definite-lived:
Customer-related$16,558$(10,360)$16,550$(9,650)
Purchased technology and patents11,640(8,151)11,600(7,514)
Trademarks and tradenames422(292)421(283)
Other357(120)355(101)
Total$28,977$(18,923)$28,925$(17,547)
Indefinite-lived:
IPR&D$281$289

Item 1. Financial Statements

FAQ

What is Medtronic's finite lived intangible assets - gross?
Medtronic (MDT) reported finite lived intangible assets - gross of $28.98B in Q4 2025.
How has Medtronic's finite lived intangible assets - gross changed year-over-year?
Medtronic's finite lived intangible assets - gross decreased by 0.2% year-over-year, from $29.04B to $28.98B.
What is the long-term trend for Medtronic's finite lived intangible assets - gross?
Over 4 years (2021 to 2025), Medtronic's finite lived intangible assets - gross has grown at a 0.0% compound annual growth rate (CAGR), from $28.88B to $28.93B.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.

Ask your AI about Medtronic's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude